Recurrent Pregnancy Loss After 35: Evaluation, Testing, and Support

Experiencing more than one pregnancy loss can bring grief, uncertainty, and pressure to find a single explanation. After 35, chromosomal differences in embryos become more common at a population level, but age should not be used to dismiss a woman’s experience or assume that evaluation has nothing to offer. Definitions and testing thresholds can vary … Ler mais

Luteal Phase After 35: What Changes and Why It Matters for Fertility

The luteal phase—the second half of the menstrual cycle, occurring after ovulation and before the next period—plays a critical but often overlooked role in fertility. For women over 35 who are trying to conceive or monitoring their cycles, understanding what happens during the luteal phase and how it may change with age can be a … Ler mais

Egg Freezing After 35: Success-Rate Context, Testing, and Decision Questions

Egg freezing can preserve unfertilized eggs for possible future use, but it cannot freeze time or guarantee a baby. After 35, decisions may feel urgent because age is relevant to both the number of eggs collected and the probability that an individual egg can lead to a live birth. Clinic estimates can be useful when … Ler mais

PCOS After 35: Fertility, Cycle Changes, and Metabolic Health Questions

Polycystic ovary syndrome can remain relevant well beyond the twenties, but its pattern may change with age. A woman who once had very irregular periods may notice shorter or more predictable cycles after 35, while concerns involving ovulation, insulin resistance, cholesterol, skin, or fertility may still deserve attention. PCOS is not defined by one symptom … Ler mais

AMH Levels After 35: What Your Results Really Mean

If you’ve recently had your AMH tested or your doctor has mentioned it, you might be wondering what the numbers actually mean for your fertility journey. Anti-Müllerian hormone is one of the most commonly discussed markers in fertility conversations today, especially for women over 35. Understanding what AMH can—and can’t—tell you is an important step … Ler mais

Egg Quality After 35: What Science Says and How to Think About It

Egg quality is one of the most discussed—and most misunderstood—aspects of fertility after 35. While it’s true that egg quality is one of the most significant factors affecting fertility in women as they age, the conversation around it is often colored by either excessive alarm or oversimplified wellness promises. What does the science actually show … Ler mais

Progesterone Levels After 35: What Research Shows About Luteal Function

Progesterone is a hormone that plays a central role in the second half of the menstrual cycle and in early pregnancy, yet it’s often less discussed than estrogen when women begin learning about hormonal health after 35. As progesterone production can become more variable with age, understanding what this hormone does, how it’s measured, and … Ler mais

Irregular Cycles After 35: When to Monitor and When to Seek Help

Menstrual cycles that once arrived with reassuring regularity can begin to shift as women move through their mid-to-late 30s. Cycles that seem to lengthen, shorten, or become less predictable are among the most common reasons women in this age group reach out to their healthcare providers. Understanding what drives these changes—and how to distinguish normal … Ler mais

Heavy Periods in Perimenopause After 35: Patterns, Iron, and When to Seek Care

Periods can become heavier, longer, closer together, or less predictable during the perimenopausal years. Hormone fluctuations may contribute, but heavy bleeding should not automatically be dismissed as a normal consequence of being over 35. Fibroids, adenomyosis, polyps, thyroid conditions, bleeding disorders, pregnancy-related causes, medications, and changes in the uterine lining can overlap. A calm evaluation … Ler mais

IUI After 35: Timing, Success-Rate Context, and Questions Before Treatment

Intrauterine insemination, often called IUI, places prepared sperm into the uterus around ovulation. After 35, the decision may involve balancing a less invasive treatment with ovarian reserve, diagnosis, sperm factors, treatment burden, cost, and the value of time. Published success rates are group averages rather than personal forecasts. Individual outcomes vary with age, egg and … Ler mais